A Randomized Phase II Trial of Erlotinib alone or in combination with Bevacizumab in Patients with Non-Small Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations
The purpose of this research study is to find out if erlotinib alone or erlotinib along with bevacizumab will work better for participants. Participants in this study have been diagnosed non-small cell lung cancer. In addition this study is to find out what effects, good and/or bad, erlotinb alone or erlotinib along with bevacizumab has on non-small cell lung cancer.
Back to Clinical Trials list